Article Figures & Data
Figures
- Fig. 1.
Management protocol of subjects with acute respiratory failure (ARF) used in our unit. This figure illustrates the routine protocol applied to patient management in case of ARF. High-flow nasal cannula (HFNC) is the first-line treatment used in de novo ARF. NIV = noninvasive ventilation.
- Fig. 2.
Subject flow chart of all admissions during the study period. Multiple oxygenation techniques may have been used in a single subject. Overall, high-flow nasal cannula (HFNC) was the first-line noninvasive treatment for 29% of respiratory failure subjects: 51 (first-line HFNC)/[51 (first-line HFNC) + 88 (NIV) + 36 (oxygen mask)] = 29%. * Detailed HFNC use of these 87 subjects is shown in Figure 3. NIV = noninvasive ventilation.
- Fig. 3.
Eighty-seven subjects had high-flow nasal cannula (HFNC) therapy at least once during ICU stay. Detailed indications are shown. ARF = acute respiratory failure, NIV = noninvasive ventilation.
